R Scott Braithwaite

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. pmc A theoretical decision model to help inform advance directive discussions for patients with COPD
    Negin Hajizadeh
    Yale Center for Medical Informatics, Yale University School of Medicine, New Haven, USA
    BMC Med Inform Decis Mak 10:75. 2010
  2. pmc Should benefit-risk assessment have its own drug "label"?
    R Scott Braithwaite
    Section of Value and Comparative Effectiveness, Division of General Internal Medicine, New York University School of Medicine, New York, NY, USA
    Drug Healthc Patient Saf 3:37-41. 2011
  3. pmc Using value of information to guide evaluation of decision supports for differential diagnosis: is it time for a new look?
    R Scott Braithwaite
    Department of Population Health, New York University School of Medicine, 550 First Avenue, VZ30 6th Floor, 615, New York, NY 10016, USA
    BMC Med Inform Decis Mak 13:105. 2013
  4. pmc Effectiveness of smoking-cessation interventions for urban hospital patients: study protocol for a randomized controlled trial
    Ellie Grossman
    Division of General Internal Medicine, New York University School of Medicine, New York, NY, USA
    Trials 13:126. 2012
  5. pmc Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?
    R Scott Braithwaite
    Section on Value and Comparative Effectiveness, Department of Medicine, New York University School of Medicine, USA
    J Int AIDS Soc 14:38. 2011
  6. ncbi request reprint Identifying favorable-value cardiovascular health services
    R Scott Braithwaite
    Section of Value and Comparative Effectiveness, Division of General Internal Medicine, NYU School of Medicine, 423 E 23rd Street, New York, NY 10010, USA
    Am J Manag Care 17:431-8. 2011
  7. doi request reprint Can life expectancy and QALYs be improved by a framework for deciding whether to apply clinical guidelines to patients with severe comorbid disease?
    R Scott Braithwaite
    Section of Value and Comparative Effectiveness, Division of General Internal Medicine, New York University School of Medicine New York, NY 10010, USA
    Med Decis Making 31:582-95. 2011
  8. pmc Could media reports include a standardized scale for quality of evidence?
    R Scott Braithwaite
    Section of Value and Comparative Effectiveness, Division of General Internal Medicine, New York University School of Medicine, New York, NY 10010, USA
    J Gen Intern Med 26:543-5. 2011
  9. pmc Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?
    R Scott Braithwaite
    New York University School of Medicine, New York, NY, USA
    Value Health 13:535-42. 2010
  10. pmc Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model
    R Scott Braithwaite
    Section of Value and Comparative Effectiveness, New York University School of Medicine, New York, New York, United States of America
    PLoS Med 7:e1000234. 2010

Collaborators

Detail Information

Publications12

  1. pmc A theoretical decision model to help inform advance directive discussions for patients with COPD
    Negin Hajizadeh
    Yale Center for Medical Informatics, Yale University School of Medicine, New Haven, USA
    BMC Med Inform Decis Mak 10:75. 2010
    ..In order to begin to inform AD discussions between clinicians and COPD patients, we constructed a decision tree to estimate the impact of alternative AD decisions on both quality and quantity of life (quality adjusted life years, QALYs)...
  2. pmc Should benefit-risk assessment have its own drug "label"?
    R Scott Braithwaite
    Section of Value and Comparative Effectiveness, Division of General Internal Medicine, New York University School of Medicine, New York, NY, USA
    Drug Healthc Patient Saf 3:37-41. 2011
    ..Strengths, weaknesses, and feasibility challenges of this approach are discussed...
  3. pmc Using value of information to guide evaluation of decision supports for differential diagnosis: is it time for a new look?
    R Scott Braithwaite
    Department of Population Health, New York University School of Medicine, 550 First Avenue, VZ30 6th Floor, 615, New York, NY 10016, USA
    BMC Med Inform Decis Mak 13:105. 2013
    ..Decision support systems for differential diagnosis have traditionally been evaluated on the basis of criteria how sensitively and specifically they are able to identify the correct diagnosis established by expert clinicians...
  4. pmc Effectiveness of smoking-cessation interventions for urban hospital patients: study protocol for a randomized controlled trial
    Ellie Grossman
    Division of General Internal Medicine, New York University School of Medicine, New York, NY, USA
    Trials 13:126. 2012
    ....
  5. pmc Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?
    R Scott Braithwaite
    Section on Value and Comparative Effectiveness, Department of Medicine, New York University School of Medicine, USA
    J Int AIDS Soc 14:38. 2011
    ..We estimated the incremental benefit and cost effectiveness of alternative monitoring strategies for east Africans with known HIV infection...
  6. ncbi request reprint Identifying favorable-value cardiovascular health services
    R Scott Braithwaite
    Section of Value and Comparative Effectiveness, Division of General Internal Medicine, NYU School of Medicine, 423 E 23rd Street, New York, NY 10010, USA
    Am J Manag Care 17:431-8. 2011
    ..To identify cardiovascular health services with a high level of evidence to suggest that they deliver favorable value...
  7. doi request reprint Can life expectancy and QALYs be improved by a framework for deciding whether to apply clinical guidelines to patients with severe comorbid disease?
    R Scott Braithwaite
    Section of Value and Comparative Effectiveness, Division of General Internal Medicine, New York University School of Medicine New York, NY 10010, USA
    Med Decis Making 31:582-95. 2011
    ..e., do not apply a guideline if a patient's life expectancy (LE) is shorter than when a guideline's cumulative incremental benefits first exceed its cumulative incremental harms), but its health impact is unclear...
  8. pmc Could media reports include a standardized scale for quality of evidence?
    R Scott Braithwaite
    Section of Value and Comparative Effectiveness, Division of General Internal Medicine, New York University School of Medicine, New York, NY 10010, USA
    J Gen Intern Med 26:543-5. 2011
    ..I outline one possible step towards a solution: medical journals can embed quality of evidence ratings in article summaries and create incentives for inclusion of these ratings in lay media reports...
  9. pmc Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?
    R Scott Braithwaite
    New York University School of Medicine, New York, NY, USA
    Value Health 13:535-42. 2010
    ..Our objective is to estimate the minimum effectiveness required for ARV adherence interventions to deliver acceptable value...
  10. pmc Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model
    R Scott Braithwaite
    Section of Value and Comparative Effectiveness, New York University School of Medicine, New York, New York, United States of America
    PLoS Med 7:e1000234. 2010
    ..Value-based insurance design (VBID) has been proposed to encourage essential care while controlling health expenditures. Our objective was to estimate the impact of broader diffusion of VBID on US health care benefits and costs...
  11. pmc A study of financial incentives to reduce plasma HIV RNA among patients in care
    Steven Farber
    Department of Medicine, Connecticut VA Healthcare System, West Haven, CT, USA
    AIDS Behav 17:2293-300. 2013
    ..It is feasible to use financial incentives to reward ART adherence, and to specify the incentive by requiring cost-neutrality and targeting biological outcomes. ..

Research Grants3

  1. A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit a
    RONALD SCOTT BRAITHWAITE; Fiscal Year: 2010
    ..This study aims to use well-tested computer simulation methods to help us assess and compare the value of different methods for preventing HIV transmission, with a focus on methods that specifically target alcohol abuse. ..
  2. A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit a
    Ronald Braithwaite; Fiscal Year: 2009
    ..This study aims to use well-tested computer simulation methods to help us assess and compare the value of different methods for preventing HIV transmission, with a focus on methods that specifically target alcohol abuse. ..
  3. A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit a
    RONALD SCOTT BRAITHWAITE; Fiscal Year: 2010
    ..This study aims to use well-tested computer simulation methods to help us assess and compare the value of different methods for preventing HIV transmission, with a focus on methods that specifically target alcohol abuse. ..